4Zhou X,Bent SJ,Schneider MG,et al.Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods.Microbiology,2004,150 (Pt 8):2565-2573.
5Kimberiy A,Workowskis MD,William C.Centers for disease control and prevention sexually transmitted diseases treatment Guidelines 2002.Recommendations and Reports,2002,51:45-47.
6Elmer GW,Surawicz CM,Mcfarland LV.Biotherapeutic agents:a neglected modality for the treatment and prevention of selected intestina ang vaginal infections.JAMA,1996,275:870-876.
7Pal Z,Dosa E,Pal A. Bacterial vagiosis and other vaginal infections[J].International Journal of Gynecology and Obstetrics,2005.278-279.doi:10.1016/j.ijgo.2005.03.005.
8Mendling W,Poli A,Magnani P. Clinical effects of nifuratel in vulvovaginal infections.A meta-analysis of metronidazole controlled trials[J].Arzneimittel-Forschung/Drug Research,2002.725-730.
